CLGN

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN)

Stock · NASDAQ · Health Care

$0.358as of 8/28/2026

Active signals

Support level
$0.303688
Industry
Industrial Specialties

About CLGN

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue filler…

Sector
Health Care
Industry
Industrial Specialties
Employees
39

Fundamentals

1-day range
$0.2637$0.4127
Market cap
$6.01M
P/E (trailing)
P/E (forward)
-0.92
EPS (trailing)
$-1.03
Dividend yield
Beta
0.79
Avg. volume
63.8K
Dividend pay date
November 21, 2016
52-week range
$0.2637$3.18
Next earnings: September 1, 2026 · EPS estimate $-0.24confirmed

CollPlant Biotechnologies Ltd Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • CLGN
    CollPlant Biotechnologies Ltd Ordinary Shares
    $0.345
    ▲ 18.97%
    Market cap $6.01MP/E
    $0.2637$3.18
  • FGI
    FGI Industries Ltd. Ordinary Shares
    $7.37
    ▼ 1.60%
    Market cap $8.30MP/E
    $3.14$19.93
  • FEED
    ENvue Medical Inc. Common Stock
    $0.3366
    ▼ 8.53%
    Market cap $3.19MP/E
    $0.29$17.4
  • NTRBW
    Nutriband Inc. Warrant
    $0.45
    ▼ 35.71%
    Market cap $3.04MP/E
    $0.25$2.99
  • NTRB
    Nutriband Inc. Common Stock
    $4.51
    ▼ 2.49%
    Market cap $34.16MP/E
    $2.8$8.63
  • MYO
    Myomo Inc. Common Stock
    $1.61
    ▼ 3.31%
    Market cap $40.18MP/E
    $0.605$1.89
  • MAMO
    Massimo Group Common Stock
    $1
    ▲ 0.00%
    Market cap $42.89MP/E 16.57
    $0.85$5.59

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.